- ►publichealth.ru [PDF] D Daneman - The Lancet, 2006 - Elsevier Type 1 diabetes accounts for only about 5–10% of all cases of diabetes;
however, its incidence continues to increase worldwide and it has serious
short-term and long-term implications. The disorder has a strong genetic ... Cited by 125 - Related articles - All 27 versions
P Betts, J Mulligan, P Ward, B Smith, T Wilkin - Diabetic Medicine, 2005 - interscience.wiley.com Aims and methods It has recently been hypothesized that weight gain in childhood
accelerates the onset of Type 1 diabetes, as well as increasing its risk, and
that Type 1 diabetes and Type 2 diabetes may be one and the same disorder ... Cited by 69 - Related articles - All 4 versions
- ►endojournals.org S Srinivasan, GR Ambler, LA Baur, SP … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: Metformin therapy for adults and children with type 2 diabetes is well
established. However, its role in the treatment of insulin resistance and
obesity in children and adolescents is less clearly defined. Cited by 64 - Related articles - BL Direct - All 6 versions
- ►endojournals.org RDG Leslie, R Williams, P Pozzilli - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: The aim of this review was to explore the pathogenic and clinical
spectrum of type 1 diabetes, which includes a form of adult onset autoimmune
diabetes usually referred to as latent autoimmune diabetes in adults ... Cited by 55 - Related articles - BL Direct - All 5 versions
- ►eje.org [PDF] S Sarnblad, M Kroon, J Aman - European Journal of Endocrinology, 2003 - eje.org Objective: Metabolic control often deteriorates during puberty in children with
type 1 diabetes. The aim of the present study was to investigate whether
addition of metformin for 3 months improves metabolic control and insulin ... Cited by 34 - Related articles - BL Direct - All 7 versions
D Russell-Jones, R Khan - Diabetes Obesity and Metabolism, 2007 - interscience.wiley.com Insulin therapy or intensification of insulin therapy commonly results in weight
gain in both type 1 and type 2 diabetes. This weight gain can be excessive,
adversely affecting cardiovascular risk profile. The spectre of weight gain ... Cited by 30 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org IM Libman, M Pietropaolo, SA Arslanian, RE … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—The black children had a higher prevalence of obesity (43 vs. 11%) and
acanthosis nigricans (21 vs. 1%) than white children and a lower prevalence of
AAs. Compared with black children who had AAs, those with no AAs were older ... Cited by 25 - Related articles - BL Direct - All 8 versions
- Free from Publisher SM Strowig, P Raskin - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Both groups experienced a significant reduction in HbA 1c (A1C) level
(rosiglitazone: 7.9 ± 1.3 to 6.9 ± 0.7%, P < 0.0001; placebo: 7.7 ± 0.8 to
7.0 ± 0.9%, P = 0.002) and a significant increase in weight ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►endojournals.org E Codner, HF Escobar-Morreale - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Context: At present, women with type 1 diabetes (DM1) are being treated with
supraphysiological doses of exogenous insulin with the aim of providing a strict
metabolic control, thereby avoiding the long-term complications of this ... Cited by 23 - Related articles - BL Direct - All 4 versions
